Edition:
United States

Destiny Pharma PLC (DEST.L)

DEST.L on London Stock Exchange

126.50GBp
12 Dec 2017
Change (% chg)

-1.00 (-0.78%)
Prev Close
127.50
Open
127.50
Day's High
--
Day's Low
--
Volume
7,032
Avg. Vol
--
52-wk High
254.75
52-wk Low
108.00

Chart for

About

Destiny Pharma PLC is a United Kingdom-based clinical stage biotechnology company. The Company is focused on the development of medicines for the treatment of infectious disease. It is developing drugs for the prevention and treatment of infections caused by Antibiotic-Resistant (AR) bacteria. The exeporfinium chloride (XF) Drug... (more)

Overall

Beta: --
Market Cap(Mil.): £54.12
Shares Outstanding(Mil.): 42.45
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 198.20 16.04
EPS (TTM): -- -- --
ROI: -- -11.76 34.69
ROE: -- -36.72 15.46

Earnings vs. Estimates